RATIONALE AND OBJECTIVES: To compare quantitative imaging parameter measures from diffusion- and perfusion-weighted imaging magnetic resonance imaging (MRI) sequences in subjects with brain tumors that have been processed with different software platforms. MATERIALS AND METHODS: Scans from 20 subjects with primary brain tumors were selected from the Comprehensive Neuro-oncology Data Repository at Washington University School of Medicine (WUSM) and the Swedish Neuroscience Institute. MR images were coregistered, and each subject's data set was processed by three software packages: 1) vendor-specific scanner software, 2) research software developed at WUSM, and 3) a commercially available, Food and Drug Administration-approved, processing platform (Nordic Ice). Regions of interest (ROIs) were chosen within the brain tumor and normal nontumor tissue. The results obtained using these methods were compared. RESULTS: For diffusion parameters, including mean diffusivity and fractional anisotropy, concordance was high when comparing different processing methods. For perfusion-imaging parameters, a significant variance in cerebral blood volume, cerebral blood flow, and mean transit time (MTT) values was seen when comparing the same raw data processed using different software platforms. Correlation was better with larger ROIs (radii ≥ 5 mm). Greatest variance was observed in MTT. CONCLUSIONS: Diffusion parameter values were consistent across different software processing platforms. Perfusion parameter values were more variable and were influenced by the software used. Variation in the MTT was especially large suggesting that MTT estimation may be unreliable in tumor tissues using current MRI perfusion methods.
RATIONALE AND OBJECTIVES: To compare quantitative imaging parameter measures from diffusion- and perfusion-weighted imaging magnetic resonance imaging (MRI) sequences in subjects with brain tumors that have been processed with different software platforms. MATERIALS AND METHODS: Scans from 20 subjects with primary brain tumors were selected from the Comprehensive Neuro-oncology Data Repository at Washington University School of Medicine (WUSM) and the Swedish Neuroscience Institute. MR images were coregistered, and each subject's data set was processed by three software packages: 1) vendor-specific scanner software, 2) research software developed at WUSM, and 3) a commercially available, Food and Drug Administration-approved, processing platform (Nordic Ice). Regions of interest (ROIs) were chosen within the brain tumor and normal nontumor tissue. The results obtained using these methods were compared. RESULTS: For diffusion parameters, including mean diffusivity and fractional anisotropy, concordance was high when comparing different processing methods. For perfusion-imaging parameters, a significant variance in cerebral blood volume, cerebral blood flow, and mean transit time (MTT) values was seen when comparing the same raw data processed using different software platforms. Correlation was better with larger ROIs (radii ≥ 5 mm). Greatest variance was observed in MTT. CONCLUSIONS: Diffusion parameter values were consistent across different software processing platforms. Perfusion parameter values were more variable and were influenced by the software used. Variation in the MTT was especially large suggesting that MTT estimation may be unreliable in tumor tissues using current MRI perfusion methods.
Authors: James R Fink; Robert B Carr; Eiji Matsusue; Ramesh S Iyer; Jason K Rockhill; David R Haynor; Kenneth R Maravilla Journal: J Magn Reson Imaging Date: 2011-10-14 Impact factor: 4.813
Authors: Ali Sami Kıvrak; Yahya Paksoy; Cengiz Erol; Mustafa Koplay; Seda Özbek; Fatih Kara Journal: Diagn Interv Radiol Date: 2013 Nov-Dec Impact factor: 2.630
Authors: C P Geer; J Simonds; A Anvery; M Y Chen; J H Burdette; M E Zapadka; T L Ellis; S B Tatter; G J Lesser; M D Chan; K P McMullen; A J Johnson Journal: AJNR Am J Neuroradiol Date: 2011-11-24 Impact factor: 3.825
Authors: Benjamin M Ellingson; Mark G Malkin; Scott D Rand; Pete S LaViolette; Jennifer M Connelly; Wade M Mueller; Kathleen M Schmainda Journal: J Neurooncol Date: 2010-08-27 Impact factor: 4.130
Authors: T Sugahara; Y Korogi; S Tomiguchi; Y Shigematsu; I Ikushima; T Kira; L Liang; Y Ushio; M Takahashi Journal: AJNR Am J Neuroradiol Date: 2000-05 Impact factor: 4.966
Authors: Leland S Hu; Jennifer M Eschbacher; Joseph E Heiserman; Amylou C Dueck; William R Shapiro; Seban Liu; John P Karis; Kris A Smith; Stephen W Coons; Peter Nakaji; Robert F Spetzler; Burt G Feuerstein; Josef Debbins; Leslie C Baxter Journal: Neuro Oncol Date: 2012-05-03 Impact factor: 12.300
Authors: Mikhail Milchenko; Abraham Z Snyder; Pamela LaMontagne; Joshua S Shimony; Tammie L Benzinger; Sarah Jost Fouke; Daniel S Marcus Journal: Neuroinformatics Date: 2016-07
Authors: Zachary S Kelm; Panagiotis D Korfiatis; Ravi K Lingineni; John R Daniels; Jan C Buckner; Daniel H Lachance; Ian F Parney; Rickey E Carter; Bradley J Erickson Journal: J Med Imaging (Bellingham) Date: 2015-05-26
Authors: Mikhail Milchenko; Scott A Norris; Kathleen Poston; Meghan C Campbell; Mwiza Ushe; Joel S Perlmutter; Abraham Z Snyder Journal: J Med Imaging (Bellingham) Date: 2018-01-08